SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS
Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions contai...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DORICH, Stéphane LANOIX, Stéphanie JONES, Paul BLACK, Cameron TRUONG, Vouy Linh TRUCHON, Jean-François ABDOLI, Abbas CRANE, Sheldon N FADER, Lee PICARD, Audrey LACBAY, Cyrus M ST-ONGE, Miguel |
| description | Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4003993A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4003993A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4003993A13</originalsourceid><addsrcrecordid>eNrjZHANDnUKDvEMCQ1xdVEw0vX1Dwrw8Pfx9PMPiAzydPH0c1VwcQ3yDHMM8QxzDVZwBKKQIAVvTz_HYFcFTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDg5hri7KGbWpAfn1pckJicmpdaEu8aYGJgYGxpaexoaEyEEgB1xiwt</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS</title><source>esp@cenet</source><creator>DORICH, Stéphane ; LANOIX, Stéphanie ; JONES, Paul ; BLACK, Cameron ; TRUONG, Vouy Linh ; TRUCHON, Jean-François ; ABDOLI, Abbas ; CRANE, Sheldon N ; FADER, Lee ; PICARD, Audrey ; LACBAY, Cyrus M ; ST-ONGE, Miguel</creator><creatorcontrib>DORICH, Stéphane ; LANOIX, Stéphanie ; JONES, Paul ; BLACK, Cameron ; TRUONG, Vouy Linh ; TRUCHON, Jean-François ; ABDOLI, Abbas ; CRANE, Sheldon N ; FADER, Lee ; PICARD, Audrey ; LACBAY, Cyrus M ; ST-ONGE, Miguel</creatorcontrib><description>Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220601&DB=EPODOC&CC=EP&NR=4003993A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220601&DB=EPODOC&CC=EP&NR=4003993A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DORICH, Stéphane</creatorcontrib><creatorcontrib>LANOIX, Stéphanie</creatorcontrib><creatorcontrib>JONES, Paul</creatorcontrib><creatorcontrib>BLACK, Cameron</creatorcontrib><creatorcontrib>TRUONG, Vouy Linh</creatorcontrib><creatorcontrib>TRUCHON, Jean-François</creatorcontrib><creatorcontrib>ABDOLI, Abbas</creatorcontrib><creatorcontrib>CRANE, Sheldon N</creatorcontrib><creatorcontrib>FADER, Lee</creatorcontrib><creatorcontrib>PICARD, Audrey</creatorcontrib><creatorcontrib>LACBAY, Cyrus M</creatorcontrib><creatorcontrib>ST-ONGE, Miguel</creatorcontrib><title>SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS</title><description>Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHANDnUKDvEMCQ1xdVEw0vX1Dwrw8Pfx9PMPiAzydPH0c1VwcQ3yDHMM8QxzDVZwBKKQIAVvTz_HYFcFTz8PTyfPEP-gYB4G1rTEnOJUXijNzaDg5hri7KGbWpAfn1pckJicmpdaEu8aYGJgYGxpaexoaEyEEgB1xiwt</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>DORICH, Stéphane</creator><creator>LANOIX, Stéphanie</creator><creator>JONES, Paul</creator><creator>BLACK, Cameron</creator><creator>TRUONG, Vouy Linh</creator><creator>TRUCHON, Jean-François</creator><creator>ABDOLI, Abbas</creator><creator>CRANE, Sheldon N</creator><creator>FADER, Lee</creator><creator>PICARD, Audrey</creator><creator>LACBAY, Cyrus M</creator><creator>ST-ONGE, Miguel</creator><scope>EVB</scope></search><sort><creationdate>20220601</creationdate><title>SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS</title><author>DORICH, Stéphane ; LANOIX, Stéphanie ; JONES, Paul ; BLACK, Cameron ; TRUONG, Vouy Linh ; TRUCHON, Jean-François ; ABDOLI, Abbas ; CRANE, Sheldon N ; FADER, Lee ; PICARD, Audrey ; LACBAY, Cyrus M ; ST-ONGE, Miguel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4003993A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DORICH, Stéphane</creatorcontrib><creatorcontrib>LANOIX, Stéphanie</creatorcontrib><creatorcontrib>JONES, Paul</creatorcontrib><creatorcontrib>BLACK, Cameron</creatorcontrib><creatorcontrib>TRUONG, Vouy Linh</creatorcontrib><creatorcontrib>TRUCHON, Jean-François</creatorcontrib><creatorcontrib>ABDOLI, Abbas</creatorcontrib><creatorcontrib>CRANE, Sheldon N</creatorcontrib><creatorcontrib>FADER, Lee</creatorcontrib><creatorcontrib>PICARD, Audrey</creatorcontrib><creatorcontrib>LACBAY, Cyrus M</creatorcontrib><creatorcontrib>ST-ONGE, Miguel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DORICH, Stéphane</au><au>LANOIX, Stéphanie</au><au>JONES, Paul</au><au>BLACK, Cameron</au><au>TRUONG, Vouy Linh</au><au>TRUCHON, Jean-François</au><au>ABDOLI, Abbas</au><au>CRANE, Sheldon N</au><au>FADER, Lee</au><au>PICARD, Audrey</au><au>LACBAY, Cyrus M</au><au>ST-ONGE, Miguel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS</title><date>2022-06-01</date><risdate>2022</risdate><abstract>Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR). Also disclosed are pharmaceutical compositions containing the compounds or pharmaceutically acceptable salts thereof and methods of their preparation and use.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4003993A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A12%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DORICH,%20St%C3%A9phane&rft.date=2022-06-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4003993A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |